PlainRecalls
FDA Drug Moderate Class II Terminated

Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31

Reported: December 19, 2018 Initiated: December 10, 2018 #D-0294-2019

Product Description

Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31

Reason for Recall

Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.

Details

Units Affected
4,404 (30 count blister packs)
Distribution
Product was distributed to 4 major distributors who distributed the product throughout the United States.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 4,404 (30 count blister packs).
Why was this product recalled?
Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 19, 2018. Severity: Moderate. Recall number: D-0294-2019.